Not exact matches
The flu
vaccine is showing higher
effectiveness for H1N1 and
influenza B strains (67 and 42 % respectively for all age groups).
Findings from this study of flu
vaccines delivered by a small needle intradermally parallel earlier results that found adding a strain of
influenza B could improve the
effectiveness of a flu
vaccine nasal spray and a traditional intramuscular
vaccine that is injected as a shot in the arm muscle.
However, even in previous years when the
vaccine has been well - matched to circulating
influenza strains,
effectiveness has been low (40 to 60 percent).
The researchers found 38 studies published between June 2011 and April 2016 that measured the
effectiveness of the inactivated pandemic
influenza vaccines, covering a population of more than 7.6 m people.
«New
influenza vaccines could, for the first time, maintain their
effectiveness in the face of viral evolution,» Subramanian says.
For some researchers the big goal is to bump up the
effectiveness of existing
vaccines, most of them made from chemically - killed
influenza particles or proteins extracted from such particles (see «Anatomy of a killer virus»).
Recent federal recommendations against offering the inhaled nasal
influenza vaccine due to lack of
effectiveness could lead to more flu illness in the U.S. if the inhaled
vaccine becomes effective again or if not having the choice of the needle-less
vaccine substantially reduces immunization rates, according to a new analysis led by University of Pittsburgh School of Medicine scientists.